Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children

Li，Xiaohe1; Wu，Liwen1,2; Qu，Youzhi3; Cao，Mengli1; Feng，Jiaqi1; Huang，Hua4; Liu，Yi1,2; Lu，Hongzhou1; Liu，Quanying3; Liu，Yingxia1

2022-12-01

英语

10.1038/s41392-022-01023-w

Signal Transduction and Targeted Therapy

7

1

2095-9907

SCI

第一 ; 通讯

2-s2.0-85133026727

Scopus

WOS:000819004700001

2059-3635

1.Shenzhen Key Laboratory of Pathogen and Immunity,National Clinical Research Center for Infectious Disease,State Key Discipline of Infectious Disease,Shenzhen Third People’s Hospital,Second Hospital Affiliated to Southern University of Science and Technology,Shenzhen,No. 29, Bulan Road, Longgang District,518112,China
2.School of Medicine,Southern University of Science and Technology,Shenzhen,518055,China
3.Shenzhen Key Laboratory of Smart Healthcare Engineering,Department of Biomedical Engineering,Southern University of Science and Technology,Shenzhen,No. 1088, Xueyuan Rd., Xili, Nanshan District, Guangdong,518055,China
4.Department of Radiology,Shenzhen Third People’s Hospital,the second affiliated hospital of Southern University of Science and Technology,National Clinical Research Center for Infectious Diseases. No. 29,Shenzhen,Bulan Road, Longgang District,518112,China

Li，Xiaohe,Wu，Liwen,Qu，Youzhi,et al. Clinical characteristics and vaccine effectiveness against SARS-CoV-2 Omicron subvariant BA.2 in the children. 2022-12-01.